The viral replication cycle

Describe the viral replication cycle as a sequence of attachment, entry, uncoating, synthesis, assembly and release, explain how the receptor molecule determines which cells a virus can infect, and name the stage that a given antiviral drug or nursing action targets.

New to this course? How each section works

Learn gives you one short idea at a time. Each idea starts with a single sentence, then explains it, gives an example, and asks you a small question you can answer straight away.
Explore shows a diagram of the same ideas. Click the numbered parts to read what each one is.
Check asks a few questions. Answer them all correctly to finish the section and unlock the next one.
“Go deeper” is optional. It adds mechanism and extra detail for when you are ready — nothing you need for the checks is hidden there.

Why this matters

Every viral illness you will nurse — a cold, influenza, shingles, HIV — is one repeated cycle happening in the patient’s cells, and the patient’s symptoms come from where that cycle damages tissue and from how the immune system answers it. Knowing the cycle tells you why HIV destroys a particular white cell and not the skin, why oseltamivir only helps if it is started early, why some viral infections clear in a week and others persist for life, and why hand hygiene and vaccination interrupt a chain you cannot see.

What you need to know first

You need the idea that a virus is acellular — a genome inside a protein coat, with no cell of its own — and the words receptor, capsid and envelope. They are defined again below, so nothing from an earlier section is assumed. No laboratory mathematics is needed.

Words to know (6)

Obligate intracellular parasite: An organism that cannot reproduce unless it is inside a living host cell, because it lacks the machinery to make proteins and copy its own genome. A virion on a dry surface does nothing; the same virion inside a cell makes hundreds of copies.
Permissive cell: A cell that a particular virus can actually use for replication, because it carries the right receptor and can supply the enzymes and building blocks the virus needs. Helper T cells are permissive for HIV; a skin cell is not.
Viral receptor: The particular molecule on the host cell surface to which a virus must bind before it can enter; its distribution decides which tissues the virus can infect. CD4 is the receptor for HIV; sialic acid is the receptor for influenza virus.
Uncoating: The stage in which the capsid is stripped away after entry so that the viral genome is released into the cytoplasm or the nucleus, where it can be read. Influenza uncoats in the endosome once the M2 channel has let acid inside the virion.
Cytopathic effect: A biochemical or structural change produced in a host cell by viral replication that alters the cell’s function or destroys it. Cells rounding up and detaching from the culture flask is a cytopathic effect.
Budding: A release strategy in which virions leave the cell one at a time through a modified patch of membrane, taking a piece of that membrane as their envelope, without lysing the cell. HIV buds from the surface of an infected helper T cell; the cell stays alive for a time.

One idea at a timeIdea 1 / 6

In one sentence A virus cannot make proteins or copy its genome by itself, so it must use a living cell for every step of its reproduction.

A virus is an obligate intracellular parasite

A virus is called an obligate intracellular parasite because it cannot reproduce on its own. A virion carries a genome and a protein coat, but it has no ribosomes to read messenger RNA into protein, no energy-generating metabolism of its own and, in most cases, no enzymes to copy its nucleic acid. Outside a living cell it is inert: it can be dried, stored and handled like a chemical, and it does nothing until it meets a cell it can use. Reproduction therefore follows an unchangeable order — attach to a living cell, be taken inside, make viral proteins and copy the viral genome, then escape so that the new virions can infect other cells. Every antiviral drug and every nursing precaution can be understood as an attempt to break one link in that chain.

For example

A used syringe left on a tray carries no activity at all until a virion reaches a susceptible cell of the next person.

Pause and check yourself

Why is a virus described as an obligate intracellular parasite rather than simply a small organism?

Show the answer

Because it owns no ribosomes and no energy metabolism, so it cannot make protein or copy its genome outside a living cell. It is not merely small; it is dependent on the host’s machinery for the two processes that define reproduction.

Read detailed explanations

Influenza from receptor to release, and the drug that blocks each stage: Influenza A repays step-by-step study because every stage has a named structure, and several of those structures are drug targets. Attachment uses haemagglutinin (HA), a surface protein that binds sialic acid residues on the ciliated cells of the respiratory epithelium; that is why influenza is a respiratory disease and why it travels in droplets. Entry follows by receptor-mediated endocytosis. Uncoating begins when the endosome becomes acidic: the viral M2 protein is a proton channel that admits hydrogen ions, the virion loosens and the viral ribonucleoproteins escape into the cytoplasm. Amantadine and rimantadine close that channel, but resistance became so widespread that they are no longer recommended. Synthesis happens in the nucleus: the viral RNA-dependent RNA polymerase copies the genome through a positive-sense intermediate and performs cap-snatching to create messenger RNA, which baloxavir marboxil inhibits. HA, neuraminidase (NA) and the other proteins are then made on the rough endoplasmic reticulum, glycosylated in the Golgi and carried to the apical membrane. Assembly and budding occur there. Release needs NA, an enzyme that cuts sialic acid and frees the new virion from the cell surface; oseltamivir and zanamivir inhibit NA, which is precisely why they shorten illness only when started within about 48 hours of the first symptoms, while large-scale virus production is still under way. The same proteins govern epidemiology: point mutations in HA and NA cause antigenic drift and seasonal epidemics, whereas reassortment of the segmented genome between human and animal strains causes antigenic shift and pandemics, as in 1918, 1957 and 1968. Nursing follows directly — annual vaccination, droplet precautions, hand hygiene, fluids and antipyretics, and early antiviral treatment for people at high risk of complications.
Lysis and budding: two release strategies with different consequences: Lysis and budding are not two ways of doing the same thing; they produce different diseases. When a virus lyses its host cell, the cell dies abruptly and releases a large burst of virions into the tissue at once. Cell contents that are normally hidden spill out and provoke inflammation, so the tissue becomes red, swollen, painful and wet. Rhinovirus in the nose and throat behaves this way, and the illness follows the release: a short incubation, an abrupt onset, and local symptoms that peak and then settle as immune cells clear the infected tissue. When a virus buds, the cell stays alive and can keep producing virions for days, weeks or years. Because the envelope is taken from the host membrane, the departing virion carries host molecules with it, and the viral glycoproteins inserted into that membrane turn the infected cell itself into a target for antibodies and cytotoxic T cells. Two clinical consequences follow. First, the immune response rather than the virus alone causes much of the illness: fever, myalgia, malaise and many viral rashes are the price of interferon and T-cell activity, which is why a patient can feel worst while the viral load is already falling. Second, a virus that does not kill its host cell can persist. Herpes simplex retreats into dorsal root ganglion neurons and stays latent for years, reappearing as a cold sore when immunity dips; varicella-zoster virus does the same and returns decades later as shingles. HIV inserts its DNA into the genome of memory helper T cells, where it can remain silent and invisible both to drugs and to immune attack, which is why antiretroviral treatment controls the infection but does not cure it and must continue for life. Budding viruses can also fuse infected cells into multinucleated syncytia, as measles and respiratory syncytial virus do, spreading infection without ever leaving the cell. The nursing implications are concrete: a patient can transmit infection while feeling entirely well, so isolation and hand hygiene cannot be based on how ill someone looks, and long-term viral production is why adherence matters more than the symptoms of any single day.
Why every stage of the cycle can be a drug target: Each step of the replication cycle offers a point of attack, and the biology of the step explains both the drug and its limits. Entry can be blocked: maraviroc occupies the CCR5 co-receptor that HIV uses to enter CD4 cells, and enfuvirtide interferes with the fusion machinery so that the viral envelope cannot merge with the cell membrane. Uncoating can be blocked: amantadine and rimantadine close the influenza M2 proton channel, preventing the acid-driven release of the genome, and resistance made them largely obsolete. Copying the genome is the richest target. Nucleoside and nucleotide analogues such as zidovudine, lamivudine and tenofovir mimic natural building blocks and terminate the growing DNA chain; efavirenz inhibits the same reverse transcriptase at a different site; acyclovir is activated only by viral thymidine kinase and then inhibits the viral DNA polymerase, which is why it spares human cells so well; sofosbuvir and remdesivir act on viral polymerases. Integration can be blocked by raltegravir, which stops the viral DNA being stitched into the host chromosome. Assembly and maturation can be blocked: HIV protease inhibitors such as ritonavir prevent the cutting of a long viral polyprotein into working enzymes and core proteins, so particles are made but are not infectious. Release can be blocked: oseltamivir prevents neuraminidase from freeing new influenza virions from the cell surface. Two principles follow. First, a good target must be essential to the virus and reasonably specific to it, which is why drugs aimed at viral enzymes harm the patient so little. Second, RNA viruses copy their genomes with an error-prone polymerase and produce enormous numbers of progeny, so resistant mutants arise easily; that is why HIV is treated with at least three drugs from different classes at once and why adherence above roughly 95 per cent is required. For nurses this explains the timing rules: oseltamivir and acyclovir work best when started early; post-exposure prophylaxis after a sharps injury should begin as soon as possible and certainly within 72 hours, continuing for 28 days; renal function is monitored in patients taking tenofovir; and patients must understand that a missed dose breeds resistant virus rather than merely delaying recovery.

Explore the diagram

Look at the whole drawing first. Then select one numbered part and connect it to the idea you just read.

The viral replication cycle: six stages, and what breaks each one

Read the chain from top to bottom. Stage 1 decides which cells can be infected at all, stages 2 and 3 deliver and unpack the genome, stage 4 copies it and makes protein, stage 5 builds the new virions, and stage 6 lets them out. The comparison at the bottom shows why lysis and budding produce different illnesses.

New to diagrams? Read this first

Look at the whole drawing once without clicking anything. Ask yourself only: what kind of picture is this (a comparison, a route, a sequence, a table)?
Press Play, or use the arrows, to move through the numbered parts in order. The drawing stays still; only the highlight moves.
Click a number, or its name in the list below, to read what that part is and why it matters. Use “Hide labels” when you want to test your memory.

More controls

100%

01 / 7Attachment: the receptor is the tropism

If the drawing is wider than this panel, scroll it sideways. Labels stay readable; the numbered explanations below show the same ideas.

Attachment: the receptor is the tropism

Outside a host the virion is inert, so meeting the right cell is a chance event, but the attachment itself is highly specific: viral surface molecules must fit receptors on the host cell. CD4 on helper T cells explains HIV, and sialic acid on respiratory epithelium explains influenza. Entry inhibitors such as maraviroc, which blocks the CCR5 co-receptor, attack this stage.

Schematic of the general replication cycle, not a scale drawing of any one virion, and not every virus follows all six stages in this order: bacteriophages inject nucleic acid and never enter as a whole particle, and some RNA viruses replicate in the cytoplasm while influenza and most DNA viruses use the nucleus. Uncoating is shown as its own stage because the supplied notes mention it at lines 1550–1551 but leave it out of their five-step list.

Key points to remember

Viruses are obligate intracellular parasites: they must attach, be taken inside, make their proteins and copy their genome, and escape to infect other cells.
A permissive cell carries the viral receptor; CD4 on helper T cells explains HIV tropism and sialic acid in the airway explains influenza tropism.
Cytopathic effects damage the cell; rhinovirus lyses its cell and releases all virions at once, while HIV buds individually without immediate lysis.
The general pattern is attachment, penetration or entry, synthesis, assembly and release, with uncoating between entry and synthesis whenever the capsid is brought inside.
Synthesis follows the genome: DNA viruses borrow host enzymes, RNA viruses copy the RNA core, and retroviruses reverse transcribe RNA into DNA, which is why viral enzymes are drug targets.

Go deeper

Worked example

Reading the cycle in a patient newly diagnosed with HIV. A 29-year-old patient is newly diagnosed with HIV after a routine test. The CD4 count is 210 cells per microlitre and the viral load is high. The patient asks why the virus attacks the immune system itself, why there were no symptoms for years and why treatment must never be interrupted. You use the replication cycle to answer, step by step.

Start with the receptor, because it explains the whole disease. HIV binds CD4, a molecule displayed mainly by helper T cells, so those are the cells it can enter. Their slow loss is what eventually removes the coordinator of the immune response, which is why the patient develops infections that a healthy person would resist.
Follow entry and uncoating to explain why the infection is permanent. The virus fuses with the cell membrane, is uncoated in the cytoplasm, and its RNA is reverse transcribed into DNA, which is then inserted into the cell’s own genome. Once inserted, the viral code is copied every time that cell divides, and some infected memory cells stop producing virus and become a silent reservoir.
Use budding to explain the long silent period. HIV leaves each helper T cell by budding rather than by lysis, so the cell survives for a time. The patient felt well for years not because the virus was inactive but because cell loss was slow and the body replaced many of the cells; the high viral load shows that replication never stopped, and the falling CD4 count shows that replacement is now losing.
Turn the cycle into the treatment plan. Reverse transcriptase, integrase and protease all belong to the virus, not to the patient’s normal metabolism, so drugs can block them with acceptable harm to the patient. Three drugs from different classes are used together because a single drug is quickly escaped by resistant mutants, which is why adherence matters more than how well the patient feels. Your nursing role is to explain that rule, give every dose on time, monitor the CD4 count, the viral load and renal function, and reinforce prevention of opportunistic infection.

The receptor explains the target cell, uncoating and reverse transcription explain why the infection is for life, budding explains the silent years, and the viral enzymes explain why the drugs work and why they must be taken together without interruption. One cycle, read in order, answers every question the patient asked.

Common misconception

Beginners often imagine that a virus is a tiny bacterium that divides by fission and is killed by antibiotics, and that the five steps are identical for every virus. Neither is true. A virus does not divide; it disassembles a cell’s normal work and forces the cell to build copies of it, and antibiotics, which act on bacterial structures such as the cell wall or the bacterial ribosome, have nothing to attack. The second error is to think of entry as one event. A bacteriophage injects its nucleic acid, a naked eukaryotic virus is engulfed, and an enveloped virus fuses — and uncoating, the stage between entry and synthesis, is a real step that a drug can block.

Check your reasoning

Choose one virus you have met in this course. Name its receptor and the cells that carry it, then say which release strategy it uses. What do those two facts predict about the illness it causes?

Reveal an answer

Take influenza virus. Its receptor is sialic acid on respiratory epithelial cells, so the infection begins in the airway and spreads in droplets; it releases by budding, so infected cells survive long enough to keep producing virions and to display viral proteins to immune cells. The prediction is a respiratory illness with fever, cough and myalgia, in which much of the misery comes from the immune response, and which can be transmitted by a person who is only mildly unwell.

Where this comes from

BMS 114 General Microbiology I lecture notes (supplied) · “Viral life cycles and oncogenesis”, “Viral life cycle”, “Virus replication cycle”, “Attachment”, “Penetration or viral entry”, “Synthesis”, “Assembly” and “Release”, lines 1491–1595
Correction to the supplied notes — penetration and uncoating · Correction to the supplied notes: lines 1525–1532 present penetration as a single uniform step and omit uncoating from the five-step list, although lines 1550–1551 name it. Entry differs fundamentally between naked and enveloped viruses and between bacteriophage and eukaryotic virus, and uncoating is a distinct stage between entry and synthesis.
Correction to the supplied notes — reverse transcription in uninfected cells · Correction to the supplied notes: lines 1567–1568 state that reverse transcription never occurs in uninfected host cells. This is a useful simplification rather than a rule, because human telomerase also synthesises DNA from an RNA template. The point that matters clinically is that retroviral reverse transcriptase is virus-encoded and absent from normal host gene expression.
Beyond the supplied notes — influenza structures and the drug that blocks each stage · haemagglutinin, neuraminidase, the M2 proton channel, cap-snatching, antigenic drift and shift, the 48-hour treatment window for oseltamivir and zanamivir, and baloxavir are standard virology and pharmacology; the notes describe the general five-step pattern at lines 1525–1587 and note only that HIV enzymes are druggable at lines 1569–1570.
Beyond the supplied notes — stage-by-stage antiviral targets and nursing timing · maraviroc, enfuvirtide, amantadine, rimantadine, zidovudine, lamivudine, tenofovir, efavirenz, raltegravir, ritonavir, aciclovir, sofosbuvir, remdesivir, combination antiretroviral therapy, the 95 per cent adherence rule, and 28-day post-exposure prophylaxis follow current pharmacology and HIV treatment guidance; the supplied notes do not name any antiviral agent.

Lesson progress is saved on this device for the current learner. Practice answers stay separate and are not stored.

About this course and its sources

Bilingual lessons organised from the supplied BMS 114 General Microbiology I lecture notes (Mr Ngotelo F. Ambene, Mr Lyonga B. Lyonga & Mr Fumbui Louis Ngong). Diagrams are original educational schematics; sections that correct the notes or go beyond them say so in their sources. Nursing and French-language review are pending.